Recomendados
Recomendados
Mais conteúdo relacionado
Mais de Rose088
Mais de Rose088 (20)
Último
Último (20)
Telik, inc. – product pipeline review – 2012
- 1. Aarkstore.com announces, The Latest market research report is available in its vast collection: Telik, Inc. – Product Pipeline Review – 2012 You can also request for sample page of above mention reports on sample@aarkstore.com Summary Global Market Direct’s pharmaceuticals report, “Telik, Inc. - Product Pipeline Review - 2012” provides data on the Telik, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Telik, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Telik, Inc. and industry- specific third party sources, put together by Global Markets Direct’s team. Scope - Telik, Inc. - Brief Telik, Inc. overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Telik, Inc. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. Table of contents: List of Tables 5
- 2. List of Figures 5 Telik, Inc. Snapshot 6 Telik, Inc. Overview 6 Key Information 6 Key Facts 6 Alexion Pharmaceuticals, Inc. – Research and Development Overview 7 Key Therapeutic Areas 7 Alexion Pharmaceuticals, Inc. – Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products – Monotherapy 11 Pipeline Products – Combination Treatment Modalities 12 Alexion Pharmaceuticals, Inc. – Pipeline Products Glance 13 Alexion Pharmaceuticals, Inc. – Late Stage Pipeline 13 Phase III Products/Combination Treatment Modalities 13 Alexion Pharmaceuticals, Inc. Clinical Stage Pipeline Products 14 Phase II Products/Combination Treatment Modalities 14 Phase I Products/Combination Treatment Modalities 15 Alexion Pharmaceuticals, Inc. – Early Stage Pipeline Products 16 Pre-Clinical Products/Combination Treatment Modalities 16 Discovery Products/Combination Treatment Modalities 17 Alexion Pharmaceuticals, Inc. – Drug Profiles 18 DNA Methyltransferase Inhibitor 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Telcyta 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 List of Figures List of Tables are also include.
- 3. For more related Reports Plz follow The link: Product Pipeline Review – 2012 http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review – 2012&PubId=&pagenum=1 Targa Therapeutics Corp. – Product Pipeline Review – 2012 Telik, Inc. – Product Pipeline Review – 2012 Wockhardt Limited – Product Pipeline Review – 2012 Zalicus Inc. – Product Pipeline Review – 2012 Actelion Ltd – Product Pipeline Review – 2012 Meda AB – Product Pipeline Review – 2012 Medivir AB – Product Pipeline Review – 2012 Nektar Therapeutics – Product Pipeline Review – 2012 Novo Nordisk A/S – Product Pipeline Review – 2012 SciClone Pharmaceuticals, Inc. – Product Pipeline Review – 2012
- 4. Search More Reports Related to This Category : Pharmaceuticals and Healthcare http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1 For More details Plz do contact : Aarkstore Enterprise Lavanya Phone:08149852585 Email: enquiry@aarkstore.com